Follistim (TM) (follitropin beta for injection)

Company
Organon

Approval Status
Approved September 1997

Treatment for
infertility

Areas
Diabetes / Endocrinology , Pregnancy & Gynecology

The U.S. Food and Drug Administration approved Oregonon's Follistim (TM) (follitropin beta for injection), the first recombinant follicle-stimulating hormone available in the U.S. for the treatment of infertility. Follistim works by stimulating ovaries to produce one or more eggs during each treatment.

Follistim Drug Information

The Follistim drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top